Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Neurofibromatosis 1 × Sirolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Myelodysplastic Syndromes 13 Lymphoma, Non-Hodgkin 13 Leukemia, Myeloid, Acute 13 Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Mantle-Cell 12 Hodgkin Disease 12 Multiple Myeloma 10 Lymphoma 10 Leukemia 10 Sarcoma 9 Lymphoma, Large B-Cell, Diffuse 9 Graft vs Host Disease 9 Burkitt Lymphoma 9 Waldenstrom Macroglobulinemia 8 Myeloproliferative Disorders 8 Lymphoma, Follicular 8 Lymphoma, B-Cell, Marginal Zone 8 Tuberous Sclerosis 6 Primary Myelofibrosis 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Large-Cell, Immunoblastic 6 Leukemia, Myelomonocytic, Chronic 6 Congenital Abnormalities 6 Breast Neoplasms 6 Lymphoma, Large-Cell, Anaplastic 5 Lymphangioleiomyomatosis 5 Leukemia, Myeloid, Chronic-Phase 5 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5 Leukemia, Myeloid, Accelerated Phase 5

Interventions

mirdametinib 2 Everolimus 2 AZD 6244 2 trametinib 1 tipifarnib 1 pirfenidone 1 peginterferon alfa-2b 1 omipalisib 1 cediranib 1 binimetinib 1 Vincristine 1 Vinblastine 1 Temozolomide 1 Sunitinib 1 Sirolimus 1 Radiotherapy 1 Methotrexate 1 Magnetic Resonance Imaging 1 Lovastatin 1 Lenalidomide 1 Inhalation 1 Ifosfamide 1 Gadolinium DTPA 1 Fluorodeoxyglucose F18 1 Filgrastim 1 Etoposide 1 Doxorubicin 1 Dosage Forms 1 Celecoxib 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00634270 2017-11-17

Protocol 102

University of Alabama at Birmingham

Phase 2 Completed

58 enrolled 19 charts

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡